Skip to main content

Akero Therapeutics, Inc.

AKRODelisted Dec 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001744659

Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Akero Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Akero Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Akero Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Harrison Seth LoringDirector0Dec 9, 20251
Iwicki Mark TDirector0Dec 9, 20251
Henderson JaneDirector0Dec 9, 20251
Gangloff Scott A.Chief Technology Officer0Dec 9, 20251
Graham G. WalmsleyDirector0Dec 9, 20252
Cheng AndrewPresident and CEO0Dec 9, 20255
White William RichardChief Financial Officer0Dec 9, 20251
Yale CatrionaChief Development Officer0Dec 9, 20252
Rolph TimothyChief Scientific Officer0Dec 9, 20254
Young JonathanChief Operating Officer0Dec 9, 20253
Heyman Tomas J.Director0Dec 9, 20251
Xu YuanDirector0Dec 9, 20251
Judy ChouDirector0Dec 9, 20251
Lamy PatrickSee Remarks0Dec 9, 20251
Ezbon International LtdOther: Former 10% owner3,271,829IndirectDec 5, 20220
Blue Horizon Enterprise LtdOther: Former 10% owner3,271,829IndirectDec 5, 20220
Montrago Trustees LtdOther: Former 10% owner3,271,829IndirectDec 5, 20220
Skorpios TrustOther: Former 10% owner3,271,829IndirectDec 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 14, 2025 (view filing)Oct 104 daysCheng AndrewPresident and CEOSSale−30.0K$53.98−$1.62M−5.4%526.1K after10b5-1
Oct 9, 2025 (view filing)Oct 72 daysRolph TimothyChief Scientific OfficerSSale−12.5K$46.08−$576.0K−7.0%166.6K after2 lots10b5-1
Oct 3, 2025 (view filing)Oct 12 daysYoung JonathanChief Operating OfficerSSale−12.5K$47.75−$596.9K−6.0%196.9K after2 lots10b5-1
Sep 12, 2025 (view filing)Sep 111 dayYoung JonathanChief Operating OfficerSSale−586$43.02−$25.2K−0.3%196.9K after
Sep 12, 2025 (view filing)Sep 111 dayYale CatrionaChief Development OfficerSSale−659$43.02−$28.4K−0.7%90.8K after
Sep 12, 2025 (view filing)Sep 111 dayWhite William RichardChief Financial OfficerSSale−659$43.02−$28.4K−1.1%57.8K after
Sep 12, 2025 (view filing)Sep 111 dayRolph TimothyChief Scientific OfficerSSale−553$43.02−$23.8K−0.3%166.6K after
Sep 12, 2025 (view filing)Sep 10-112 daysCheng AndrewPresident and CEOSSale−31.8K$43.23−$1.37M−6.3%473.9K after4 lots10b5-1
Sep 10, 2025 (view filing)Sep 82 daysRolph TimothyChief Scientific OfficerSSale−12.5K$44.17−$552.1K−7.0%167.1K after2 lots10b5-1
Sep 4, 2025 (view filing)Sep 22 daysYoung JonathanChief Operating OfficerSSale−12.5K$46.09−$576.1K−6.0%197.5K after3 lots10b5-1
Aug 13, 2025 (view filing)Aug 121 dayYoung JonathanChief Operating OfficerSSale−12.5K$47.78−$597.3K−6.0%197.5K after2 lots10b5-1
Aug 13, 2025 (view filing)Aug 112 daysCheng AndrewPresident and CEOSSale−30.0K$48.59−$1.46M−5.8%490.8K after3 lots10b5-1
Aug 12, 2025 (view filing)Aug 12Same dayHenderson JaneDirectorSSale−3.00K$47.46−$142.4K−24.2%9.40K after
Aug 7, 2025 (view filing)Aug 52 daysRolph TimothyChief Scientific OfficerSSale−12.5K$49.30−$616.3K−7.0%167.1K after2 lots10b5-1
Jul 18, 2025 (view filing)Jul 162 daysYale CatrionaChief Development OfficerSSale−10.0K$52.95−$529.5K−9.9%91.5K after2 lots10b5-1
Jul 11, 2025 (view filing)Jul 101 dayCheng AndrewPresident and CEOSSale−30.0K$51.16−$1.53M−5.4%520.8K after2 lots10b5-1
Jul 9, 2025 (view filing)Jul 72 daysRolph TimothyChief Scientific OfficerSSale−12.5K$51.09−$638.6K−7.0%167.1K after3 lots10b5-1
Jul 3, 2025 (view filing)Jul 12 daysLamy PatrickSenior VP, Commercial StrategySSale−2.00K$52.88−$105.8K−6.3%29.9K after10b5-1
Jun 20, 2025 (view filing)Jun 182 daysCheng AndrewPresident and CEOSSale−6.62K$54.84−$363.0K−1.2%549.9K after
Jun 20, 2025 (view filing)Jun 182 daysGangloff Scott A.Chief Technology OfficerSSale−848$54.84−$46.5K−3.5%23.5K after
Jun 20, 2025 (view filing)Jun 20Same dayLamy PatrickSenior VP, Commercial StrategySSale−875$54.59−$47.8K−2.7%31.7K after
Jun 20, 2025 (view filing)Jun 182 daysRolph TimothyChief Scientific OfficerSSale−1.13K$54.84−$61.9K−0.7%166.2K after
Jun 20, 2025 (view filing)Jun 182 daysWhite William RichardChief Financial OfficerSSale−1.63K$54.84−$89.6K−2.8%57.5K after
Jun 20, 2025 (view filing)Jun 182 daysYale CatrionaChief Development OfficerSSale−1.63K$54.84−$89.6K−1.8%90.6K after
Jun 20, 2025 (view filing)Jun 182 daysYoung JonathanChief Operating OfficerSSale−1.45K$54.84−$79.7K−0.7%196.6K after
Jun 20, 2025 (view filing)Jun 164 daysLateYale CatrionaChief Development OfficerSSale−10.0K$54.23−$542.3K−9.8%92.2K after3 lots10b5-1
Jun 20, 2025 (view filing)Jun 164 daysLateLamy PatrickSenior VP, Commercial StrategySSale−2.00K$54.14−$108.3K−5.8%32.6K after2 lots10b5-1
Jun 12, 2025 (view filing)Jun 102 daysCheng AndrewPresident and CEOSSale−37.8K$54.04−$2.04M−6.4%556.5K after3 lots10b5-1
Jun 12, 2025 (view filing)Jun 102 daysRolph TimothyChief Scientific OfficerSSale−2.36K$54.00−$127.3K−1.4%167.4K after
Jun 12, 2025 (view filing)Jun 102 daysWhite William RichardChief Financial OfficerSSale−2.80K$54.00−$151.4K−4.5%59.2K after
Jun 12, 2025 (view filing)Jun 102 daysYale CatrionaChief Development OfficerSSale−2.80K$54.00−$151.4K−2.9%92.2K after
Jun 12, 2025 (view filing)Jun 102 daysLamy PatrickSenior VP, Commercial StrategySSale−919$54.00−$49.6K−2.7%32.6K after
Jun 12, 2025 (view filing)Jun 102 daysYoung JonathanChief Operating OfficerSSale−2.49K$53.99−$134.6K−1.2%198.0K after
Jun 9, 2025 (view filing)Jun 5-64 daysRolph TimothyChief Scientific OfficerSSale−37.5K$54.52−$2.04M−18.1%169.7K after3 lots10b5-1
Jun 4, 2025 (view filing)Jun 22 daysLamy PatrickSenior VP, Commercial StrategySSale−4.00K$50.32−$201.3K−10.7%33.5K after3 lots10b5-1
May 23, 2025 (view filing)May 221 dayLamy PatrickSenior VP, Commercial StrategySSale−4.00K$50.00−$200.0K−10.7%33.5K after10b5-1
May 19, 2025 (view filing)May 154 daysYale CatrionaChief Development OfficerSSale−10.0K$39.30−$393.0K−9.5%95.0K after3 lots10b5-1
May 13, 2025 (view filing)May 121 dayCheng AndrewPresident and CEOSSale−30.0K$41.48−$1.24M−4.8%594.3K after2 lots10b5-1
May 9, 2025 (view filing)May 72 daysLamy PatrickSenior VP, Commercial StrategySSale−8.00K$42.50−$340.0K−19.3%33.5K after2 lots10b5-1
May 8, 2025 (view filing)May 62 daysRolph TimothyChief Scientific OfficerSSale−12.5K$43.43−$542.8K−6.9%169.7K after3 lots10b5-1
Apr 28, 2025 (view filing)Apr 244 daysRolph TimothyChief Scientific OfficerSSale−6.25K$41.03−$256.4K−3.6%169.7K after10b5-1
Apr 16, 2025 (view filing)Apr 151 dayYale CatrionaChief Development OfficerSSale−9.07K$37.91−$343.9K−8.7%95.0K after2 lots10b5-1
Apr 11, 2025 (view filing)Apr 101 dayCheng AndrewPresident and CEOSSale−30.0K$35.23−$1.06M−4.6%624.3K after10b5-1
Apr 10, 2025 (view filing)Apr 73 daysLateRolph TimothyChief Scientific OfficerSSale−6.25K$35.88−$224.3K−3.6%169.7K after4 lots10b5-1
Mar 27, 2025 (view filing)Mar 25-272 daysGraham G. WalmsleyDirectorPPurchase+200.0K$43.94+$8.79M+20.0%1.20M after3 lots
Mar 18, 2025 (view filing)Mar 171 dayYale CatrionaChief Development OfficerSSale−10.0K$44.76−$447.6K−9.5%95.0K after2 lots10b5-1
Mar 14, 2025 (view filing)Mar 122 daysCheng AndrewPresident and CEOSSale−1.74K$44.88−$78.0K−0.3%654.3K after
Mar 14, 2025 (view filing)Mar 122 daysYoung JonathanChief Operating OfficerSSale−607$44.88−$27.2K−0.3%200.5K after
Mar 14, 2025 (view filing)Mar 122 daysYale CatrionaChief Development OfficerSSale−614$44.88−$27.6K−0.6%95.0K after
Mar 14, 2025 (view filing)Mar 122 daysWhite William RichardChief Financial OfficerSSale−676$44.88−$30.3K−1.1%62.0K after